Saphris 10 MG Sublingual Tablet

RxCUI: 859979
RxNorm name: Saphris 10 MG Sublingual Tablet
Display name: Saphris 10 MG Sublingual Tablet
Full name: Saphris 10 MG Sublingual Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SAPHRIS	ASENAPINE MALEATE	Allergan, Inc.	5429f134-839f-4ffc-9944-55f51238def8	2025-01-31	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 859979

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
5429f134-839f-4ffc-9944-55f51238def8	Saphris 10 MG Sublingual Tablet	SY	22	These highlights do not include all the information needed to use SAPHRIS (asenapine) sublingual tablets safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS ® (asenapine) sublingual tablets Initial U.S. Approval: 2009	20250131
5429f134-839f-4ffc-9944-55f51238def8	asenapine 10 MG Sublingual Tablet [Saphris]	SBD	22	These highlights do not include all the information needed to use SAPHRIS (asenapine) sublingual tablets safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS ® (asenapine) sublingual tablets Initial U.S. Approval: 2009	20250131
5429f134-839f-4ffc-9944-55f51238def8	Saphris 10 MG Sublingual Tablet	PSN	22	These highlights do not include all the information needed to use SAPHRIS (asenapine) sublingual tablets safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS ® (asenapine) sublingual tablets Initial U.S. Approval: 2009	20250131
03c696e9-0e6b-4e5c-be0a-41416f8019be	Saphris 10 MG Sublingual Tablet	PSN	1	These highlights do not include all the information needed to use SAPHRIS ® (asenapine) safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS (asenapine) sublingual tablets Initial U.S. Approval: 2009	20110216
03c696e9-0e6b-4e5c-be0a-41416f8019be	Saphris 10 MG Sublingual Tablet	SY	1	These highlights do not include all the information needed to use SAPHRIS ® (asenapine) safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS (asenapine) sublingual tablets Initial U.S. Approval: 2009	20110216
03c696e9-0e6b-4e5c-be0a-41416f8019be	asenapine 10 MG Sublingual Tablet [Saphris]	SBD	1	These highlights do not include all the information needed to use SAPHRIS ® (asenapine) safely and effectively. See full prescribing information for SAPHRIS. SAPHRIS (asenapine) sublingual tablets Initial U.S. Approval: 2009	20110216